PFC Capital Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,085
Closed -$539K 88
2025
Q1
$539K Sell
1,085
-40
-4% -$21.7K 0.27% 63
2024
Q4
$585K Sell
1,125
-80
-7% -$44K 0.28% 53
2024
Q3
$745K Buy
1,205
+159
+15% +$94.1K 0.36% 49
2024
Q2
$578K Buy
1,046
+46
+5% +$26.4K 0.29% 52
2024
Q1
$581K Sell
1,000
-20
-2% -$11.2K 0.31% 51
2023
Q4
$541K Buy
+1,020
New +$494K 0.32% 50

Other funds holding TMO

PFC Capital Group's TMO Position: Q2 2025 in Review

PFC Capital Group sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 1,085 shares — an estimated $539K sold.

PFC Capital Group first reported a position in TMO in Q4 2023 and held it in 6 quarters. The position peaked at $745K in Q3 2024. 2,457 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

  • PFC Capital Group reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
  • PFC Capital Group sold 1,085 Thermo Fisher Scientific shares in Q2 2025, an estimated $539K.
  • PFC Capital Group first reported a position in Thermo Fisher Scientific in Q4 2023 and held it in 6 quarters.
  • PFC Capital Group's Thermo Fisher Scientific position peaked at $745K in Q3 2024.
  • 2,457 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on PFC Capital Group's 13F filing for Q2 2025, filed 12 Aug 2025.